Technical Analysis for CODX - Co-Diagnostics, Inc.

Grade Last Price % Change Price Change
F 1.21 0.00% 0.00
CODX closed unchanged on Friday, November 1, 2024, on 24 percent of normal volume. Its advance stalled at its 200 day moving average, an important long-term support / resistance line.
Earnings due: Nov 7
*** please verify all earnings dates ***
3 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
200 DMA Resistance Bearish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
BB Squeeze + Lower Band Touch Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Gapped Down Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
200 DMA Resistance Bearish -0.82%
Bollinger Band Squeeze Range Contraction -0.82%
BB Squeeze + Lower Band Touch Range Contraction -0.82%

   Recent Intraday Alerts

Alert Time
Fell Below Lower Bollinger Band about 22 hours ago
Down 2 % about 22 hours ago
Down 1% about 22 hours ago
Lower Bollinger Band Support about 22 hours ago
60 Minute Opening Range Breakdown about 22 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Co-Diagnostics, Inc. Description

Co-Diagnostics, Inc. is a molecular diagnostics company. The Company is engaged in developing, manufacturing and marketing diagnostics technology. Its reagents are used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules, such as deoxyribonucleic acid and ribonucleic acid. It also sells diagnostic equipment from other manufacturers as self-contained lab systems (MDx device). The Company uses its proprietary test design system and proprietary reagents to design and sell polymerase chain reaction diagnostic tests for diseases and pathogens starting with tests for tuberculosis, a drug resistant tuberculosis test, hepatitis B and C, Malaria, dengue, human immunodeficiency virus and Zika virus, all of which tests have been designed and validated in its laboratory. Its diagnostics systems enable molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests.


Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Biotechnology Clinical Medicine Disease Acid Medical Test Hepatitis B Molecular Diagnostics Diagnostic Tests Genetic Diseases Immunodeficiency Malaria Organisms Diagnostic Equipment Tuberculosis Ortho Clinical Diagnostics Polymerase Chain Reaction Dengue Zika Dengue Fever

Is CODX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 2.2299
52 Week Low 1.0
Average Volume 218,316
200-Day Moving Average 1.23
50-Day Moving Average 1.29
20-Day Moving Average 1.26
10-Day Moving Average 1.24
Average True Range 0.07
RSI (14) 44.13
ADX 25.81
+DI 17.11
-DI 13.61
Chandelier Exit (Long, 3 ATRs) 1.19
Chandelier Exit (Short, 3 ATRs) 1.38
Upper Bollinger Bands 1.34
Lower Bollinger Band 1.18
Percent B (%b) 0.19
BandWidth 12.57
MACD Line -0.02
MACD Signal Line -0.01
MACD Histogram -0.0046
Fundamentals Value
Market Cap 37 Million
Num Shares 30.6 Million
EPS -1.39
Price-to-Earnings (P/E) Ratio -0.87
Price-to-Sales 8.14
Price-to-Book 0.37
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.28
Resistance 3 (R3) 1.28 1.26 1.27
Resistance 2 (R2) 1.26 1.24 1.26 1.27
Resistance 1 (R1) 1.23 1.23 1.23 1.23 1.26
Pivot Point 1.21 1.21 1.21 1.21 1.21
Support 1 (S1) 1.18 1.19 1.19 1.19 1.16
Support 2 (S2) 1.16 1.18 1.16 1.15
Support 3 (S3) 1.13 1.16 1.15
Support 4 (S4) 1.14